Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability.
about
Analysis of the regulation of fatty acid binding protein 7 expression in human renal carcinoma cell linesIndications for biopsy and the current status of focal therapy for renal tumoursRenal tumors: diagnostic and prognostic biomarkersEmerging critical role of molecular testing in diagnostic genitourinary pathologySerum and urine biomarkers for human renal cell carcinomaLenvatinib therapy for the treatment of patients with advanced renal cell carcinoma.Imaging the clear cell renal cell carcinoma proteome.Analysis of various potential prognostic markers and survival data in clear cell renal cell carcinoma.High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinomaAssociation of serum amyloid A protein and peptide fragments with prognosis in renal cancer.Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinomaLack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinoma.Screening and identification of a renal carcinoma specific peptide from a phage display peptide library.Heterogeneity and renal mass biopsy: a review of its role and reliability.Expression and significance of histone H3K27 demethylases in renal cell carcinoma.Telomere length in relation to immunological parameters in patients with renal cell carcinomaPrognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasisPrognostic significance of ST3GAL-1 expression in patients with clear cell renal cell carcinomaExpression and prognostic significance of zinc fingers and homeoboxes family members in renal cell carcinoma.Epigenetic change in kidney tumor: downregulation of histone acetyltransferase MYST1 in human renal cell carcinoma.High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma.From bench to bedside: current and future applications of molecular profiling in renal cell carcinomaExpression analysis and in silico characterization of intronic long noncoding RNAs in renal cell carcinoma: emerging functional associations.A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC).Mutations in the Mitochondrial ND1 Gene Are Associated with Postoperative Prognosis of Localized Renal Cell Carcinoma.Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasis.CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinomaEnrichment of C5a-C5aR axis predicts poor postoperative prognosis of patients with clear cell renal cell carcinoma.The expression and role of tyrosine kinase ETK/BMX in renal cell carcinomaA three-molecule score based on Notch pathway predicts poor prognosis in non-metastasis clear cell renal cell carcinomaPrognostic role of N-Acetylgalactosaminyltransferase 10 in metastatic renal cell carcinoma.Rereading the renal cell tumors.What can molecular pathology contribute to the management of renal cell carcinoma?How far is the horizon? From current targets to future drugs in advanced renal cancer.Biomarkers in renal cancer.The urinary proteome and peptidome of renal cell carcinoma patients: a comparison of different techniques.Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.Should Small Renal Masses Be Biopsied?Metastatic renal cell carcinoma imaging evaluation in the era of anti-angiogenic therapies.Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma.
P2860
Q24611370-51027DE9-DCA7-46C3-A2D7-58EAF100B61BQ26773659-1B763F11-2004-4C6A-81CF-289390017A4AQ26860500-77307904-4424-40DA-B633-4CBAA2E14EDBQ27021371-45F94F07-8ADD-496E-BBEC-724E82A95885Q28084949-6CB8EEA6-0B9E-44BA-955B-DAFACB75807AQ30249385-150E2865-163D-4DA7-B60C-BA6234DB494EQ30457782-C19645A3-8383-494A-A3AC-A7F3A430661CQ31126032-100942EC-5287-47BC-841E-695049571683Q33555276-D0E2F1B7-A414-48C5-8F62-471CB482C429Q33597715-C2136CD9-37BF-40AC-94EF-C7A5E5794463Q33710169-12AF3E6E-CA4F-4B8F-8434-28726591283AQ33904883-7F5B7FEF-EA67-4F59-BA49-70BF363EC3B8Q34070986-FA03D4E6-EF9F-4E1C-955A-82A183C5401FQ34340943-F75FC00B-F2CE-4F83-A87B-A6D115D8F04CQ34443684-15E8E670-E011-4570-8FC6-E7838E1AE81FQ34577167-258098F1-1EB6-4DEA-8763-1AFE894D1821Q34995476-44DE9DA3-1331-44E2-A632-287683038C81Q35836524-BB9B146E-1EE2-4320-92B4-01E5CE0CA1C0Q36267604-AC36A0E4-3E37-4E1F-85C6-CCF59642D7C2Q36624382-AABEDE09-FC98-4BFB-9D1B-8C61DA5CDBDEQ37067601-396FB656-B79A-4A4D-A624-A03F5EA3C3F8Q37154789-11DB109A-5022-4823-8ACC-A15934C6EF5CQ37326719-23085BA2-81D9-4684-8B94-09C301529890Q37470131-C88963F5-ECE2-4714-BE9C-DB0650A83A46Q37534703-1B0355A1-43B4-44FB-B464-C307A56D70DBQ37573641-B7E862DA-06B8-4CB7-92D4-1691F4101920Q37588317-C1CEFACC-7B2B-42DF-8416-E4937DAD7AE9Q37697095-879767C2-41B5-4A47-8795-EC7BFE746FF5Q37699758-5469A796-720D-4571-8C22-968A8B230A72Q37708831-7B13B623-5FD4-4A02-BA3C-34C8D0F16078Q37716481-4010F355-4D77-4E58-9C51-F8D147552902Q37756379-ABACFA63-9271-4E74-9E38-6BC918CD5F7BQ37864528-05A6FCF1-A008-42B8-8DFB-C7AD203ECEA4Q38105251-FB7FC4FD-AB57-4B91-AD7A-2A84585F1C3CQ38184386-17BB7F2A-8001-44BC-BD09-793F2A7D902AQ38217103-E059A56E-5F98-40A0-ABB9-81509B6DD23EQ38679148-CB7D66DD-CC40-475F-955C-48CACAF5664DQ38758628-E98CB59F-F3E3-4EF6-A606-65221F71D3E7Q38837758-29A8C7DB-1FF0-47C6-B020-CAB10F61F40BQ39166678-5075FA45-290C-42BA-9235-731F7B5BA336
P2860
Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diagnostic and prognostic mole ...... ch and clinical applicability.
@en
Diagnostic and prognostic mole ...... ch and clinical applicability.
@nl
type
label
Diagnostic and prognostic mole ...... ch and clinical applicability.
@en
Diagnostic and prognostic mole ...... ch and clinical applicability.
@nl
prefLabel
Diagnostic and prognostic mole ...... ch and clinical applicability.
@en
Diagnostic and prognostic mole ...... ch and clinical applicability.
@nl
P2093
P1433
P1476
Diagnostic and prognostic mole ...... ch and clinical applicability.
@en
P2093
Christian Eichelberg
Holger Moch
Kerstin Junker
P304
P356
10.1016/J.EURURO.2009.01.003
P407
P577
2009-01-13T00:00:00Z